Related Experiment Video
Updated: Aug 12, 2026
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Clinical features and electrocardiogram parameters in Parkinson's disease
Hitoshi Mochizuki1, Nobuyuki Ishii1, Kazutaka Shiomi1
1Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, University of Miyazaki, Japan.
Neurology International
|April 6, 2018
Summary
Electrocardiogram (ECG) parameters correlate with clinical features in Parkinson's disease (PD) patients. Specific ECG intervals reflect disease progression and autonomic dysfunction, guiding clinical attention.
Area of Science:
- Neurology
- Cardiology
- Medical Diagnostics
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder affecting motor function.
- Autonomic dysfunction is a common non-motor symptom in PD.
- Electrocardiogram (ECG) parameters may offer insights into PD pathophysiology.
Purpose of the Study:
- To investigate the relationship between clinical features and ECG parameters in PD patients.
- To determine if ECG parameters can serve as indicators of disease progression or autonomic dysfunction in PD.
Main Methods:
- Analysis of clinical data including body mass index (BMI), age, disease duration, and Hoehn and Yahr stage from 156 PD patients.
- Measurement and analysis of ECG parameters: RR, PR, QRS, QT intervals, and heart rate-corrected QT (QTc).
- Statistical correlation analysis between clinical features and ECG parameters.
Main Results:
- Body mass index (BMI) showed a positive correlation with PR and QRS intervals.
- QRS interval positively correlated with disease duration and Hoehn and Yahr stage.
- QT interval and QTc showed a positive correlation with patient age.
- Significant associations were found between various clinical features and ECG parameters.
Conclusions:
- Clinical features and ECG parameters are closely associated in Parkinson's disease.
- Certain ECG parameters, such as QRS, QT, and QTc intervals, may reflect disease progression and autonomic dysfunction.
- Increased attention to ECG parameters in PD patient management is warranted.
More Related Videos
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
06:07Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
Published on: June 23, 2023
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...